Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,897–3,904 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Sorrento Therapeutics Inc. Abivertinib - (MAVERICK) Metastatic Castrate Resistant Prostate Cancer Phase 2 Oral Oncology
Sorrento Therapeutics Inc. STI-2099 - (COVI-DROPS) COVID-19 Phase 2 Intranasal COVID-19
Sorrento Therapeutics Inc. COVI-MSC (MSC-COV-202BR) COVID-19 / Acute Respiratory Distress Syndrome Phase 2 Intravenous COVID-19
Sorrento Therapeutics Inc. Resiniferatoxin (RTX) - (OAK) OsteoArthritis (OA) Knee Pain Phase 2 Intrathecal Orthopedic
Sorrento Therapeutics Inc. Resiniferatoxin Intractable Pain Associated with Cancer Phase 2 Intrathecal Opioid Analgesic
Sorrento Therapeutics Inc. STI-3031 Urothelial carcinoma Phase 2a oral Oncology
Spero Therapeutics Inc. Tebipenem HBr (SPR994) - (PIVOT-PO) Complicated urinary tract infection (cUTI), including acute pyelonephritis (AP) NDA Filing Ongoing Oral Antibiotic
Spero Therapeutics Inc. Tebipenem HBr (SPR994) - (ADAPT-PO) Complicated urinary tract infections (cUTI) Phase 3 Withdrawn Oral N/A